Namely, only 5% of patients with high-high CD45RO+ and CD8+ TILs in their colon cancer experienced recurrence, as compared to 75% of relapses among those patients whose tumors harbored low-low densities of these TILs. The gene discussed is CD8A; the disease is malignant colon neoplasm.